Quarterly report pursuant to Section 13 or 15(d)

Related Party Disclosure

v3.10.0.1
Related Party Disclosure
6 Months Ended
Jun. 30, 2018
Related Party Transactions [Abstract]  
Related Party Disclosure

9. Related Party Disclosure

Consulting Agreement with Michael Kauffman

On April 1, 2017, the Company entered into a consulting agreement with Michael Kauffman, a member of its board of directors. This agreement provides that Dr. Kauffman shall provide clinical and scientific advisory services and participate on the Company’s board of directors in exchange for a monthly fee of $3,000, payable on the first of the month. The consulting agreement terminated in June 2018 in connection with the Company’s IPO. For the three and six months ended June 30, 2018, the Company recognized $8,100 and $17,100, respectively as consulting expense for the agreement. For the three and six months ended June 30, 2017, the Company recognized $9,000 as consulting expense for the agreement.